Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

Aghajanian, 2000, Serotonin model of schizophrenia: emerging role of glutamate mechanisms, Brain Res, 31, 302, 10.1016/S0165-0173(99)00046-6 Alex KD (2007) 5-HT2C serotonin receptors: cellular localization and control of dopaminergic pathways in the rat brain. Ph.D. Dissertation, Case Western Reserve University, January, 2007. Alex, 2007, Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission, Pharmacol Ther, 113, 296, 10.1016/j.pharmthera.2006.08.004 Aloyo, 2001, Selective and divergent regulation of cortical 5-HT2A receptors in rabbit, J Pharmacol Exp Ther, 299, 1066 Andersson, 1995, Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system, Naunyn Schmiedebergs Arch Pharmacol, 352, 374, 10.1007/BF00172774 Arora, 1991, Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients, J Neural Transm, 85, 19, 10.1007/BF01244654 Bagdy, G., Graf, M., Anheuer, Z.E., Modos, E.A. and Kantor, S. (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 4(4):399–408. Barker, 1994, Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands, J Biol Chem, 269, 11687, 10.1016/S0021-9258(17)32625-X Barnard, 1998, International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function, Pharmacol Rev, 50, 291 Benjamin, 1999, Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder, Psychopharmacology, 143, 215, 10.1007/s002130050938 Benjamin, 1990, The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze, Life Sci, 47, 195, 10.1016/0024-3205(90)90320-Q Berg, 2001, Regulation of 5-HT1A and 5-HT1B receptor systems by phospholipid signaling cascades, Brain Res Bull, 56, 471, 10.1016/S0361-9230(01)00645-1 Berg, 2006, Development of functionally selective agonists as novel therapeutic agents, Drug Discov Today Ther Strateg, 3, 421, 10.1016/j.ddstr.2006.10.017 Berg, 1994, Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems, Mol Pharmacol, 46, 477 Berg, 2008, A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling, J Pharmacol Exp Ther, 324, 1084, 10.1124/jpet.107.131524 Berg, 1999, Novel actions of inverse agonists on 5-HT2C receptor systems, Mol Pharmacol, 55, 863 Berg, 2001, Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation, J Pharmacol Exp Ther, 299, 593 Bilkei-Gorzo, 1998, mCPP-induced anxiety in the light–dark box in rats—a new method for screening anxiolytic activity, Psychopharmacology, 136, 291, 10.1007/s002130050568 Black, 1985, An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation, Br J Pharmacol, 84, 561, 10.1111/j.1476-5381.1985.tb12941.x Bourne, 1997, How receptors talk to trimeric G proteins, Curr Opin Cell Biol, 9, 134, 10.1016/S0955-0674(97)80054-3 Bristow, 2000, Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat, Neuropharmacology, 39, 1222, 10.1016/S0028-3908(99)00191-4 Burnet, 1996, 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia, Neuropsychopharmacology, 15, 442, 10.1016/S0893-133X(96)00053-X Burns, 1997, Regulation of serotonin-2C receptor G-protein coupling by RNA editing, Nature, 387, 303, 10.1038/387303a0 Campbell, 2003, Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment, Brain Res, 993, 1, 10.1016/S0006-8993(03)03384-5 Cassaday, 2003, Intraventricular 5,7-dihydroxytryptamine lesions disrupt acquisition of working memory task rules but not performance once learned, Prog Neuro-psychopharmacol Biol Psychiatry, 27, 147, 10.1016/S0278-5846(02)00346-9 Cassaday, 2001, Serotonergic depletion increases conditioned suppression to background stimuli in the rat, J Psychopharmacol (Oxford, England), 15, 83, 10.1177/026988110101500204 Ceglia, 2004, The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC, J Neurochem, 91, 189, 10.1111/j.1471-4159.2004.02704.x Chanrion, 2008, Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction, Mol Pharmacol, 73, 748, 10.1124/mol.107.041574 Charney, 1987, Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects, Psychopharmacology, 92, 14, 10.1007/BF00215473 Chidiac, 1996, Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor, Mol Pharmacol, 50, 662 Christopoulos, 2002, G protein-coupled receptor allosterism and complexing, Pharmacol Rev, 54, 323, 10.1124/pr.54.2.323 Conn, 1986, Agonist-induced phosphoinositide hydrolysis in choroid plexus, J Neurochem, 47, 1754, 10.1111/j.1471-4159.1986.tb13085.x Cornelio, 2007, Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze, Behav Brain Res, 178, 82, 10.1016/j.bbr.2006.12.003 Costa, 1989, Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins, Proc Natl Acad Sci U S A, 86, 7321, 10.1073/pnas.86.19.7321 Dave, 2007, The time–course for up- and down-regulation of the cortical 5-hydroxytryptamine (5-HT)2A receptor density predicts 5-HT2A receptor-mediated behavior in the rabbit, J Pharmacol Exp Ther, 323, 327, 10.1124/jpet.107.121707 De Deurwaerdere, 2004, Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens, J Neurosci, 24, 3235, 10.1523/JNEUROSCI.0112-04.2004 De Deurwaerdere, 2001, The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors, Trends Pharmacol Sci, 22, 502, 10.1016/S0165-6147(00)01811-3 de Mello Cruz, 2005, Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze, Psychopharmacology, 182, 345, 10.1007/s00213-005-0108-2 Di Giovanni, 1999, Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study, Neuroscience, 91, 587, 10.1016/S0306-4522(98)00655-1 Di Giovanni, 2006, Central serotonin2C receptor: from physiology to pathology, Curr Top Med Chem, 6, 1909, 10.2174/156802606778522113 Di Matteo, 2001, Role of 5-HT(2C) receptors in the control of central dopamine function, Trends Pharmacol Sci, 22, 229, 10.1016/S0165-6147(00)01688-6 Egan, 1998, Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs, J Pharmacol Exp Ther, 286, 85 Eison, 1989, Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation, Life Sci, 44, 1419, 10.1016/0024-3205(89)90400-1 Fitzgerald, 1999, Messenger RNA editing of the human serotonin 5-HT2C receptor, Neuropsychopharmacology, 21, 82S, 10.1038/sj.npp.1395328 Fletcher, 1999, Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward, Pschopharmacology (Berl), 147, 291, 10.1007/s002130051170 Gainetdinov, 2004, Desensitization of G protein-coupled receptors and neuronal functions, Annu Rev Neurosci, 27, 107, 10.1146/annurev.neuro.27.070203.144206 Gatch, 2003, Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety, Life Sci, 73, 1347, 10.1016/S0024-3205(03)00422-3 Gether, 1997, Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility, J Biol Chem, 272, 2587, 10.1074/jbc.272.5.2587 Ginn, 1986, Pizotifen attenuates classical eye-blink and heart rate conditioning in rabbits, Physiol Psychol, 14, 36 Gobert, 2000, Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat, Synapse (New York, NY, 36, 205, 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D González-Maeso, 2008, Identification of a serotonin/glutamate receptor complex implicated in psychosis, Nature, 452, 93, 10.1038/nature06612 Gudermann, 1997, Functional and structural complexity of signal transduction via G-protein-coupled receptors, Annu Rev Neurosci, 20, 399, 10.1146/annurev.neuro.20.1.399 Hackler, 2007, 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation, J Pharmacol Exp Ther, 320, 1023, 10.1124/jpet.106.113357 Harvey, 1996, Serotonergic regulation of associative learning, Behav Brain Res, 73, 47 Harvey, 2003, Role of the serotonin 5-HT(2A) receptor in learning, Learn Memory (Cold Spring Harbor, NY, 10, 355, 10.1101/lm.60803 Harvey, 2004, Selective remodeling of rabbit frontal cortex: relationship between 5-HT2A receptor density and associative learning, Psychopharmacology, 172, 435, 10.1007/s00213-003-1687-4 Hasuo, 2002, Activation of presynaptic 5-hydroxytryptamine 2A receptors facilitates excitatory synaptic transmission via protein kinase C in the dorsolateral septal nucleus, J Neurosci, 22, 7509, 10.1523/JNEUROSCI.22-17-07509.2002 Hernandez, 2000, Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment, J Nneurosci Res, 59, 218, 10.1002/(SICI)1097-4547(20000115)59:2<218::AID-JNR8>3.0.CO;2-H Herrick-Davis, 1999, Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction, J Neurochem, 73, 1711, 10.1046/j.1471-4159.1999.731711.x Herrick-Davis, 2000, Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors, J Pharmacol Exp Ther, 295, 226 Hoyer, 1993, Partial agonists, full agonists, antagonists: dilemmas of definition, Trends Pharmacol Sci, 14, 270, 10.1016/0165-6147(93)90129-8 Hurlemann, 2008, 5-HT2A receptor density is decreased in the at-risk mental state, Psychopharmacology, 195, 579, 10.1007/s00213-007-0921-x Jakab, 1998, 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites, Proc Natl Acad Sci U S A, 95, 735, 10.1073/pnas.95.2.735 Jones, 2002, 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze, Psychopharmacology, 164, 214, 10.1007/s00213-002-1197-9 Kahn, 1991, m-Chlorophenylpiperazine as a probe of serotonin function, Biol Psychiatry, 30, 1139, 10.1016/0006-3223(91)90184-N Kenakin, 1994, On the definition of efficacy, Trends Pharmacol Sci, 15, 408, 10.1016/0165-6147(94)90086-8 Kenakin, 1996, The classification of seven transmembrane receptors in recombinant expressions systems, Pharmacol Rev, 48, 413 Kenakin, 2001, Inverse, protean, and ligand-selective agonism: matters of receptor conformation, Faseb J, 15, 598, 10.1096/fj.00-0438rev Kenakin, 2005, The physiological significance of constitutive receptor activity, Trends Pharmacol Sci, 26, 603, 10.1016/j.tips.2005.10.007 Kenakin, 1985, Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity, J Cardiovasc Pharmacol, 7, 208, 10.1097/00005344-198501000-00033 Kennett, 1995, Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety, Psychopharmacology, 118, 178, 10.1007/BF02245837 Kennett, 1989, Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists, Eur J Pharmacol, 164, 445, 10.1016/0014-2999(89)90252-5 Kennett, 1997, SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist, Neuropharmacology, 36, 609, 10.1016/S0028-3908(97)00038-5 Klein, 1991, Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects, Biol Pychiatry, 30, 973, 10.1016/0006-3223(91)90119-7 Kobilka, 2007, Conformational complexity of G-protein-coupled receptors, Trends Pharmacol Sci, 28, 397, 10.1016/j.tips.2007.06.003 Kuoppamaki, 1995, Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs, Neuropsychopharmacology, 13, 139, 10.1016/0893-133X(95)00049-J Lambe, 2000, Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat, Cereb Cortex, 10, 974, 10.1093/cercor/10.10.974 Laruelle, 1993, Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study, Arch Gen Psychiatry, 50, 810, 10.1001/archpsyc.1993.01820220066007 Leeb-Lundberg, 2001, The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains, J Biol Chem, 276, 8785, 10.1074/jbc.M007396200 Leff, 1995, The two-state model of receptor activation, Trends Pharmacol Sci, 16, 89, 10.1016/S0165-6147(00)88989-0 Leff, 1997, A three-state receptor model of agonist action, Trends Pharmacol Sci, 18, 355, 10.1016/S0165-6147(97)01105-X Leurs, 1998, Agonist-independent regulation of constitutively active G-protein-coupled receptors, Trends Biochem Sci, 23, 418, 10.1016/S0968-0004(98)01287-0 Leysen, 2004, 5-HT2 receptors, Curr Drug Targets, 3, 11 Liu, 2007, Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction, Neuroscience, 146, 1677, 10.1016/j.neuroscience.2007.02.064 Lowy, 1988, Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist, Biol Psychiatry, 23, 818, 10.1016/0006-3223(88)90070-4 Marquis, 2007, WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity, J Pharmacol Exp Ther, 320, 486, 10.1124/jpet.106.106989 Martin, 2002, Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety, Pharmacol Biochem Behav, 71, 615, 10.1016/S0091-3057(01)00713-4 Martin, 1998, 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential, J Pharmacol Exp Ther, 286, 913 Meltzer, 1999, The role of serotonin in antipsychotic drug action, Neuropsychopharmacology, 21, 106S, 10.1016/S0893-133X(99)00046-9 Meltzer, 1989, Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values, J Pharmacol Exp Ther, 251, 238 Millan, 2006, Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies, Thérapie, 60, 441, 10.2515/therapie:2005065 Milligan, 1997, Inverse agonism and the regulation of receptor number, Trends Pharmacol Sci, 18, 468, 10.1016/S0165-6147(97)01139-5 Miner, 2003, Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex, Neuroscience, 116, 107, 10.1016/S0306-4522(02)00580-8 Mueller, 1985, Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans, J Clin Endocrinol Metab, 61, 1179, 10.1210/jcem-61-6-1179 Muschamp, 2004, Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex, Brain Res, 1023, 134, 10.1016/j.brainres.2004.07.044 Nair, 2004, Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat, Synapse (New York, NY, 53, 202, 10.1002/syn.20054 Navailles, 2006, Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors, J Neurochem, 99, 1311, 10.1111/j.1471-4159.2006.04188.x Newman-Tancredi, 2002, Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes, J Pharmacol Exp Ther, 303, 815, 10.1124/jpet.102.039883 Nichols, 2004, Hallucinogens, Pharmacol Ther, 101, 131, 10.1016/j.pharmthera.2003.11.002 Niswender, 1999, RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity, J Biol Chem, 274, 9472, 10.1074/jbc.274.14.9472 Niswender, 1998, Identification and characterization of RNA editing events within the 5-HT2C receptor, Ann N Y Acad Sci, 861, 38, 10.1111/j.1749-6632.1998.tb10171.x Pazos, 1987, Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors, Neuroscience, 21, 123, 10.1016/0306-4522(87)90327-7 Price, 2001, RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein, J Biol Chem, 276, 44663, 10.1074/jbc.M106745200 Quirion, 1985, Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex, Brain Res, 333, 345, 10.1016/0006-8993(85)91590-2 Rauser, 2001, Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor, J Pharmacol Exp Ther, 299, 83 Reavill, 1999, Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist, Br J Pharmacol, 126, 572, 10.1038/sj.bjp.0702350 Rodgers, 1992, Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP, Behav Pharmacol, 3, 621, 10.1097/00008877-199212000-00009 Romano, 2000, Dissociable effects of the 5-HT(2) antagonist mianserin on associative learning and performance in the rabbit, Pharmacol Biochem Behav, 67, 103, 10.1016/S0091-3057(00)00298-7 Romano, 2006, Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo, Psychopharmacology, 184, 173, 10.1007/s00213-005-0245-7 Roth, 1998, 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function, Pharmacol Ther, 79, 231, 10.1016/S0163-7258(98)00019-9 Samama, 1993, A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model, J Biol Chem, 268, 4625, 10.1016/S0021-9258(18)53442-6 Schmidt, 1992, 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine, Eur J Pharmacol, 223, 65, 10.1016/0014-2999(92)90819-P Seifert, 2002, Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 366, 381, 10.1007/s00210-002-0588-0 Shapiro, 2002, Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6, J Biol Chem, 277, 11441, 10.1074/jbc.M111675200 Sharp, 1989, 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis, Br J Pharmacol, 96, 283, 10.1111/j.1476-5381.1989.tb11815.x Sharp, 1989, Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis, Br J Pharmacol, 98, 989, 10.1111/j.1476-5381.1989.tb14630.x Shepherd, 1994, Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety, Psychopharmacology, 116, 56, 10.1007/BF02244871 Simpson, 1996, RNA editing, Ann Rev Neurosci, 19, 27, 10.1146/annurev.ne.19.030196.000331 Smith, 1997, A guide to RNA editing, RNA (New York, NY, 3, 1105 Sodhi, 2001, RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia, Mol Psychiatry, 6, 373, 10.1038/sj.mp.4000920 Southwick, 1997, Noradrenergic and serotonergic function in posttraumatic stress disorder, Arch Gen Psychiatry, 54, 749, 10.1001/archpsyc.1997.01830200083012 Stout, 2002, Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence, J Pharmacol Exp Ther, 302, 957, 10.1124/jpet.302.3.957 Strange, 2002, Mechanisms of inverse agonism at G-protein-coupled receptors, Trends Pharmacol Sci, 23, 89, 10.1016/S0165-6147(02)01993-4 Teitler, 2002, Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors, Curr Top Med Chemi, 2, 529, 10.2174/1568026023393859 Urban, 2007, Functional selectivity and classical concepts of quantitative pharmacology, J Pharmacol Exp Ther, 320, 1, 10.1124/jpet.106.104463 Verhoeff, 2000, A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia, Psychiatry Res, 99, 123, 10.1016/S0165-1781(00)00198-0 Wang, 2000, Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors, J Neurochem, 74, 1290, 10.1046/j.1471-4159.2000.741290.x Ward, 1999, Forebrain serotonin depletion facilitates the acquisition and performance of a conditioned visual discrimination task in rats, Behav Brain Res, 100, 51, 10.1016/S0166-4328(98)00112-0 Weiner, 2001, 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics, J Pharmacol Exp Ther, 299, 268 Welsh, 1998, Effects of LSD, ritanserin, 8-OH-DPAT, and lisuride on classical conditioning in the rabbit, Pharmacol Biochem Behav, 59, 469, 10.1016/S0091-3057(97)00436-X Welsh, 1998, Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit, Psychopharmacology, 137, 157, 10.1007/s002130050605 Wess, 1998, Molecular basis of receptor/G-protein-coupling selectivity, Pharmacol Ther, 80, 231, 10.1016/S0163-7258(98)00030-8 Westphal, 1995, Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization, Mol Pharmacol, 48, 200 Wilbanks, 2002, Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors, Biochemistry, 41, 11981, 10.1021/bi020275m Wilkinson, 1995, Differential effects of forebrain 5-hydroxytryptamine depletions on Pavlovian aversive conditioning to discrete and contextual stimuli in the rat, Eur J Neurosci, 7, 2042, 10.1111/j.1460-9568.1995.tb00627.x Willins, 1997, Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex, Synapse, 27, 79, 10.1002/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A Wood, 2003, Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders, Curr Drug Targets, 2, 383 Wood, 2001, SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, Neuropharmacology, 41, 186, 10.1016/S0028-3908(01)00054-5